Tissue wound repair has been studied extensively. It involves the coordinated activation of several intracellular and intercellular pathways, as well as remodeling from the sequential recruitment of different cell types to the wound site. There is, however, an equally important process that happens at the single cell level, when the integrity of the plasma membrane is compromised. Individual eukaryotic cells can rapidly repair their plasma membrane after injury, through a process that restores internal homeostasis and prevents cell death. Despite its importance, investigations of this fascinating mechanism have been limited. Only recently have we begun to understand that plasma-membrane repair resembles tissue healing, in the sense that it also involves sequential, highly localized remodeling steps that ultimately eliminate all traces of the injury.
Ca
2+ infl ux as a trigger By actively pumping Ca 2+ ions from the cytosol into the extracellular space, cells maintain cytosolic resting concentrations of calcium in the nanomolar range. This results in a steep gradient across the plasma membrane, which serves as the only separation from an extracellular environment containing very high, millimolar concentrations of Ca 2+ . When the integrity of the plasma membrane is breached, a rapid infl ux of Ca 2+ generates localized and transient increases in the cytosolic free Ca 2+ concentration . Early studies in sea urchin eggs showed that Ca 2+ infl ux through plasma membrane wounds triggered a rapid surface reaction followed by full restoration of the eggs' integrity, allowing subsequent fertilization and normal development. In contrast, when Ca 2+ was removed from the seawater surrounding the eggs, wounding resulted in progressive loss of cytosol and cell death. These initial observations were confi rmed in mammalian cells, establishing the concept that infl ux of extracellular Ca 2+ into injured cells is essential for triggering that upon Ca 2+ infl ux through the wound, pre-existing intracellular vesicles would fuse with each other to form a membrane 'patch', which would then merge with the injured plasma membrane restoring its integrity. This is supported by electron microscopic observation of large intracellular vesicles close to wound sites and the rapid formation of a diffusion barrier when Ca 2+ -rich solutions were injected into oocytes. The second model proposed that reduced plasma membrane tension resulting from multiple exocytic events close to a wound would facilitate transition from a disordered lipid phase to a continuous planar lipid bilayer. This model is supported by direct measurements of reduced plasma membrane tension after injury. Despite limitations in these early models, there is a strong consensus that Ca 2+ -regulated exocytosis of endomembrane vesicles, a few seconds after injury, is essential for plasma membrane repair.
The term 'constitutive exocytosis' refers to the process by which newly synthesized molecules are delivered to the plasma membrane of eukaryotic cells or secreted into the extracellular medium. Molecules secreted through constitutive exocytosis are fi rst translocated into the endoplasmic reticulum and traffi c through the Golgi complex, where they are packaged into vesicles that ultimately fuse with the plasma membrane. 

2+
-regulated exocytosis A major breakthrough in our understanding of plasma membrane repair came when experiments in sea urchin eggs and mammalian cells revealed extensive and localized fusion of intracellular vesicles with the plasma membrane, a few seconds after injury and Ca 2+ infl ux. Inhibiting vesicle exocytosis by interfering with the formation of SNARE complexes impaired plasma membrane resealing, leading to the fi rst two models that explain the mechanism of plasma membrane repair ( Figure 1A,B) . The fi rst model proposed Current Biology 28, R367-R420, April 23, 2018 R393 the ubiquitous population of exocytic vesicles that mediate plasma membrane repair. Exocytosis of lysosomes has been extensively observed in injured cells, and plasma membrane repair is impaired after inhibition of lysosomal exocytosis. Impaired plasma membrane repair is also seen after inhibition of synaptotagmin 7, a member of the synaptotagmin family of Ca 2+ sensors present on the membrane of lysosomes, or of components of SNARE complexes that mediate lysosome exocytosis. Interestingly, inhibition of the lysosomal Ca 2+ channel mucolipin-1 also impairs plasma membrane repair, suggesting that Ca 2+ stored in the lumen of lysosomes may also contribute to the increase in cytosolic Ca 2+ concentration that is critical for plasma membrane resealing.
Exocytosis of lysosomes as a defense
So why did 'dangerous' organelles such as lysosomes, which have a very low luminal pH and contain a large load of degradative enzymes, evolve for the fundamental role of plasma membrane repair? The use of lysosomes for this role is at fi rst glance counter-intuitive, but this perception changes when one considers that prokaryotes are likely to have represented a major early threat to the plasma membrane integrity of eukaryotic cells. The single lipid bilayer that surrounds eukaryotic cells enabled the development of dynamic membrane fusion/fi ssion events, which gave rise to complex organelles and robust intracellular membrane traffi c. In contrast, bacteria are often protected by more rigid cell walls and evolved an arsenal of membrane damaging agents that include pore-forming toxins and specialized secretion systems that permeabilize eukaryotic membranes and promote Ca 2+ infl ux. Given that eukaryotic cells and bacteria co-evolved for millions of years, it is conceivable that before the appearance of multicellular organisms there was no signifi cant barrier to prevent frequent contacts between these two cell types. Thus, a response to plasma membrane injury in the form of lysosomal exocytosis might have provided a strong evolutionary advantage to eukaryotic cells. Lysosomes contain numerous molecules and enzymes that can compromise the viability of bacteria, and a localized release of these agents at the site of the injury might have reduced the microbes' ability to infl ict Figure 1 . Proposed mechanisms of plasma membrane repair. Ca 2+ infl ux through plasma membrane wounds triggers exocytosis. Initially it was proposed that this would result in formation of a repair 'patch' (A) and/or a reduction in membrane tension facilitating spontaneous resealing (B). More recent studies proposed that lesions are actively removed from the membrane, through a massive form of endocytosis that follows Ca 2+ -triggered lysosomal exocytosis (C), or by the shedding of ESCRT complexdependent membrane buds in the case of small lesions (D).
R394 Current Biology 28, R367-R420, April 23, 2018 further damage, in addition to promoting plasma membrane resealing (Figure 2 ). Consistent with this view of lysosomes as primordial exocytic organelles engaged in cellular defense, it is noteworthy that cytotoxic lymphocytes perform their critical role in immune defense by secreting the contents of lysosomerelated organelles, in a very localized and targeted fashion. As discussed below, evidence is emerging that extracellularly released lysosomal enzymes may also remodel the outer leafl et of the plasma membrane to facilitate wound repair.
Lesion removal by endocytosis
Bacterial pore-forming toxins, such as Streptolysin O (SLO), are useful tools for studying plasma membrane repair, because pre-binding of toxin monomers at low temperatures followed by warming allows synchronization of the wounding step. Studies using this system have revealed that mammalian cells can fully restore their plasma membrane integrity after permeabilization with SLO, and concluded that this process has several elements in common with the resealing of mechanical wounds. First, SLO-pore repair is also strictly dependent on the presence of Ca 2+ in the extracellular medium. Second, restoration of plasma membrane integrity is also rapid, being completed within ~30 seconds after SLO permeabilization. Third, lysosomal exocytosis is also required for the repair of SLO pores. These common properties suggested that a common mechanism involving lysosomal exocytosis might be involved in the resealing of different types of lesions, as long as they allow Ca 2+ infl ux. However, it became very diffi cult to envision how the originally proposed 'patch' or 'tension reduction' models of plasma membrane repair could promote the resealing of stable, protein-lined transmembrane pores. Instead, it became necessary to identify a mechanism capable of physically removing pores from the plasma membrane.
A different model for plasma membrane repair began to emerge when mammalian cells injured mechanically or by SLO pores were found to undergo massive endocytosis, after Ca Current Biology 28, R367-R420, April 23, 2018 R395 defi ned the interval between elevation of intracellular Ca 2+ concentration and endocytosis as approximately 30 seconds, closely mirroring the time scale of plasma membrane repair. This injurydependent massive endocytic process offered an alternative explanation for the intracellular vesicle accumulation that is seen close to wounds, which were previously considered primarily exocytic. This unusual form of endocytosis observed after Ca 2+ infl ux is independent of classical endocytosis proteins such as clathrin, requires the presence of cholesterol in the plasma membrane, and can be triggered by extracellular exposure to the enzyme sphingomyelinase. These fi ndings provided useful opportunities for functional inhibition studies, which demonstrated a requirement for injury-dependent endocytosis in lesion removal from the plasma membrane. Providing an important link between lysosomal exocytosis and endocytosis-mediated plasma membrane repair, the lysosomal enzyme acid sphingomyelinase (ASM) was found to promote endocytosis and plasma membrane resealing when added extracellularly to cells injured mechanically or by SLO permeabilization. Collectively, these fi ndings led to a multi-step model of plasma membrane repair (Figure 3) . According to this model, plasma membrane injury triggers Ca 2+ infl ux and exocytosis of lysosomal hydrolases, including ASM, which in turn remodel the outer leafl et of the plasma membrane. This triggers a ceramidedependent wave of endocytosis that internalizes the lesions. Experiments following the intracellular fate of SLO in resealed cells have shown that the internalized toxin travels down the endocytic pathway and is delivered to lysosomes for degradation (Figure 3) .
Caveolae are plasma membrane invaginations with a diameter of ~80 nm that are associated with membrane microdomains enriched in cholesterol and sphingomyelin (frequently described as lipid rafts). Caveolae are present in many cell types, and particularly abundant in cells that are under signifi cant mechanical stress in vivo such as muscle fi bers, cardiomyocytes and endothelial cells. Caveolae were described to detach from the plasma membrane and become internalized after certain stimuli, but there is still controversy about the frequency of this event and its physiological role. Interestingly, electron microscopy studies have revealed a large number of internalized vesicles with the size and morphology of caveolae in the Figure 3 . Plasma membrane injury triggers a repair response that involves exocytosis of lysosomes followed by lesion endocytosis and intracellular degradation. Ca 2+ infl ux through plasma membrane wounds triggers localized exocytosis of lysosomes, releasing enzymes that remodel the cell surface facilitating lesion endocytosis. After internalization in endosomes, membrane lesions traffi c to the lumen of lysosomes where they are degraded.
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Current Biology 28, R367-R420, April 23, 2018 cytoplasm of injured cells, or in intact cells treated with sphingomyelinase. SLO was directly visualized traveling into cells inside internalized caveolar vesicles, and inhibition of caveolae formation blocked plasma membrane repair, strongly suggesting that wounds can be removed from the plasma membrane through caveolar endocytosis. Interestingly, intracellular caveolae-like vesicles were reported to accumulate inside the highly fragile skeletal muscle fi bers of Duchenne muscular dystrophy patients, suggesting that a weak sarcolemma may lead to frequent cycles of injury and caveolae-mediated repair. These fi ndings add to the growing evidence that point to cholesterol-dependent, clathrin-independent endocytosis as a pathway to remove plasma membrane lesions in mammalian cells. In B lymphocytes, cells that do not appear to contain morphologically-defi ned caveolae, plasma membrane wounding triggers an ASM-dependent, clathrinindependent form of lipid raft endocytosis that is associated with Ca 2+ -dependent lysosomal exocytosis and plasma membrane repair. These are exciting developments, because they suggest that the poorly understood pathway of clathrin-independent endocytosis of cholesterol and sphingomyelin-enriched lipid rafts may have a central role in promoting plasma membrane repair.
Are lesions also removed by blebbing and shedding?
A frequent observation in wounded cells is the formation of highly dynamic, large plasma membrane blebs (in the µm range). This morphologically striking surface reaction has led, understandably, to the assumption that shedding of injured membrane in the form of blebs might represent a mechanism by which cells remove lesions and reseal their plasma membrane. However, careful investigations suggest that large wounding-induced plasma membrane blebs do not detach from cells, but rather refl ect transient, reversible Ca 2+ -dependent disassembly of the cortical actin cytoskeleton. Consistent with this view, drugs that abolish formation of large plasma membrane blebs do not inhibit cell resealing. On the other hand, genetic depletion experiments have implicated components of the ESCRT complex, which promotes membrane deformation and vesicle budding away from the cytosol, in the repair of small plasma membrane wounds ( Figure 1D ). It is important to note that the ESCRT-generated vesicles seen so far in other systems are much smaller (around 50 nm) than the transient, large plasma membrane blebs commonly seen in injured cells. Thus, for fi rmly implicating ESCRT-mediated vesicle shedding in plasma membrane repair, it will be important to show that ESCRTdependent vesicles in the predicted size range are formed in the plasma membrane and then shed from wounded cells. These additional experiments are important to rule out potential noncanonical roles of ESCRT components in plasma membrane repair, or the possibility that the ESCRT complex promotes plasma membrane remodeling at a later step, after resealing.
Plasma membrane repair and disease
Many tissues are under mechanical stress in vivo, which at the cellular level is expected to result in frequent cycles of plasma membrane injury and repair. This is particularly true for skeletal muscle, where frequent injury during exercise is well documented through the entry of membrane impermeant molecules and extracellularly released cytosolic markers such as creatine kinase and lactate dehydrogenase. In agreement with a critical need to restore plasma membrane integrity after injury in muscle, genetic mutations in several proteins involved in plasma membrane repair are increasingly being found to cause muscle pathology. Autosomal recessive mutations in dysferlin, a sarcolemma protein with multiple Ca 2+ -binding C2 domains, underlie a late onset form of human limbgirdle muscular dystrophy (LGMD2B). A similar pathology develops in dysferlinnull mice, and knockout mice lacking the lysosomal Ca 2+ sensor Sy7 develop a form of infl ammatory myopathy with foci of muscle fi ber death and infi ltration by infl ammatory cells. Another form of human limb girdle muscular dystrophy, LGMD2A, is associated with autosomal recessive mutations in the Ca 2+ -activated protease calpain 3a. Mouse cells lacking the lysosomal Ca 2+ channel mucolipin-1 are also defective in plasma membrane resealing after injury, and knockout animals develop early onset progressive muscular dystrophy. In humans mucolipin-1 mutations cause the severe lysosomal storage disease mucolipidosis type IV, which is characterized by progressive neurodegeneration, motor dysfunction and muscle weakness in addition to more generalized symptoms such as retinal degeneration and anemia.
The realization that endocytosis plays a role in plasma membrane repair has provided important new insights into the pathology associated with mutations in caveolae-specifi c proteins. Mutations in the muscle-specifi c caveolin-3 isoform Cav3 cause an autosomal dominant form of muscular dystrophy in humans (LGMD1C). Cavin (PTRF) mutations are linked to cardiomyopathy and various forms of skeletal muscle pathology in humans. In mice, Cav1 (the ubiquitously expressed caveolin-1 isoform) defi ciency is associated with impairment in endothelial relaxation/ contractility, defective maintenance of myogenic tone and lung fi brosis, while animals lacking both Cav1 and Cav3 develop severe cardiomyopathy. These caveolin/cavin-linked pathological changes are associated with a complete absence of caveolae on the plasma membrane, and have been attributed to defects in signaling and/or lipid metabolism. However, the demonstration that lesions can be directly removed from the plasma membrane through caveolar internalization suggests that defective plasma membrane repair may represent, at least in part, a component of the muscle pathology associated with the lack of caveolae. Reinforcing this view, Cav3 binds to two additional muscle proteins important for plasma membrane repair, dysferlin and mitsugumin 53, forming a complex that may regulate membrane traffi c events essential for plasma membrane repair. As our understanding of the molecular machinery mediating plasma membrane repair increases, more human diseases associated with this process are likely to be identifi ed, paving the way for future therapeutic approaches.
Outlook
Despite major progress in recent years, several aspects of the plasma membrane repair mechanism remain poorly understood. Understanding how cells reseal very large plasma membrane wounds represents a particular challenge. Repair of large wounds was proposed to occur by the gradual constriction of plasma membrane openings driven by massive Current Biology 28, R367-R420, April 23, 2018 © 2018 Elsevier Ltd. R397 endocytosis, or through a membranous patch. Regarding the 'patch hypothesis', it has been hard to envision how a large, three-dimensional intracellular vesicle formed by homotypic fusion could be transformed into a two-dimensional membrane patch and used to reseal an irregular plasma membrane wound. One proposed mechanism was 'vertex fusion', whereby a series of fusion pores would form between the margins of a plasma membrane wound and the top of a large intracellular vesicle, restoring plasma membrane continuity after lateral expansion of the fusion pores and extracellular shedding of a large membrane fragment. Thus, biochemical experiments searching for evidence of released plasma membrane fragments are an important future priority for strengthening the evidence supporting both the 'patch' and ESCRT-mediated budding models of plasma membrane repair. More studies are also required to investigate the interesting possibility that the repair response may be regulated by the extent of Ca 2+ infl ux, with high levels of Ca 2+ entry triggering additional responses needed for the repair of large wounds.
A very interesting development in the fi eld of plasma membrane repair is the growing evidence that this mechanism can be co-opted for other cellular functions. Lysosomal exocytosis followed by vigorous endocytosis was observed in cells targeted by the cytotoxic lymphocyte pore-forming protein perforin, and the 'leaky' endosomes formed in this manner were proposed to represent a major site where granzymes cross into the cytosol to trigger cell death. In B cells, there is evidence that plasma membrane repair utilizes the same lipid raft membrane microdomains involved in antigen recognition and internalization. Ca 2+ triggered lysosomal exocytosis and ASM-dependent endocytosis are subverted by the protozoan parasite Trypanosoma cruzi to invade host cells, and it will be of great interest to determine if this pathway can also promote infection by other intracellular pathogens. Finally, plasma membrane repair is likely to play an important role in controlling infl ammation associated with tissue injury, and this should be an exciting and fertile area for future investigation. 
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